PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Guanfacine
Presentation Product Chemical substance Chapter Items dispensed
Guanfacine 2mg modified-release tablets
0404000V0AAADAD
Guanfacine Guanfacine Central Nervous System 3,847
Guanfacine 1mg modified-release tablets
0404000V0AAACAC
Guanfacine Guanfacine Central Nervous System 3,672
Guanfacine 3mg modified-release tablets
0404000V0AAAAAA
Guanfacine Guanfacine Central Nervous System 3,304
Guanfacine 4mg modified-release tablets
0404000V0AAABAB
Guanfacine Guanfacine Central Nervous System 2,754
Intuniv 2mg modified-release tablets
0404000V0BBADAD
Intuniv Guanfacine Central Nervous System 2,751
Intuniv 3mg modified-release tablets
0404000V0BBAAAA
Intuniv Guanfacine Central Nervous System 2,512
Intuniv 4mg modified-release tablets
0404000V0BBABAB
Intuniv Guanfacine Central Nervous System 2,292
Intuniv 1mg modified-release tablets
0404000V0BBACAC
Intuniv Guanfacine Central Nervous System 2,256
Guanfacine 5mg modified-release tablets
0404000V0AAAEAE
Guanfacine Guanfacine Central Nervous System No data available
Guanfacine 6mg modified-release tablets
0404000V0AAAFAF
Guanfacine Guanfacine Central Nervous System No data available
Guanfacine 7mg modified-release tablets
0404000V0AAAGAG
Guanfacine Guanfacine Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.